NGFR and melanoma: Thus in a previous study we undertook a novel strategy by targeting a combination of melanoma associated antigens, MCSP and MCAM and previously described stem-cell markers, ATP-binding cassette sub-family B member (ABCB5) [18] and CD271 [19], to enrich CTCs.